Many rare coding mutations and intronic single nucleotide polymorphisms in CLCN6 have been related with decreased blood pressure and hypertension, along with stroke risk as based on recent GWAS findings in humans [54]. This evidence concerns the gene CLCN6 and hypertensive disorder.